Table 4.

Pooled sorafenib treatment vs. capecitabine treatment.

Pooled Analysis	N pts	Sorafenib	N pts	Capecitabina	Effect size	p-value
Age	120	53,8 yrs (51,0–56,7)	17	53,5 yrs (49,3–57,7)	0,014	0,451
Extra-hepatic recurrence	120	56,2% (34,3–76,0)	17	52,9% (29,2–76,6)	0,043	>0,999
Additional treatments	120	57,6% (38,7–74,6)	17	41,1% (17,7–64,5)	0,367	0,297
Swith m-TOR	110	61,7% (40,4–79,2)	17	35,3% (12,6–58,0)	0,597	0,122
1-year survival	120	57,7% (46,5–68,2)	17	68,5% (46,4–90,6)	0,251	0,431